Are There Any Risks Associated with Recombinant Clotting Factors?
While generally safe, recombinant clotting factors can still pose some risks, including: - Allergic Reactions: Though rare, some neonates may experience allergic reactions. - Inhibitor Development: In some cases, patients may develop inhibitors that neutralize the efficacy of the treatment. - Thrombosis: Excessive administration can lead to thrombotic complications, although this is uncommon in neonates.
